No Data
Porton Pharma Solutions Ltd.'s (SZSE:300363) 8.5% Gain Last Week Benefited Both Retail Investors Who Own 43% as Well as Insiders
Boteng shares: 2024 third quarter report
Porton Pharma Solutions (300363.SZ): Net loss of 36.3932 million yuan in the third quarter.
On October 24, Porton Pharma Solutions (300363.SZ) announced its third quarter report for 2024. In the third quarter of 2024, the company achieved revenue of 0.773 billion yuan, a year-on-year increase of 10.73%; net income attributable to shareholders of the listed company was a loss of 36.3932 million yuan, a year-on-year decrease of 187.72%; net income after deducting non-recurring gains and losses was a loss of 39.393 million yuan, a year-on-year decrease of 211.61%; basic earnings per share were a loss of 0.07 yuan per share.
Porton Pharma Solutions (300363.SZ) released its performance for the first three quarters, with a net loss of 0.206 billion yuan.
Porton Pharma Solutions (300363.SZ) released the third quarter report for 2024, with revenue of 21...
Porton Pharma Solutions Ltd.'s (SZSE:300363) 38% Price Boost Is Out Of Tune With Revenues
Investors in Porton Pharma Solutions (SZSE:300363) From Three Years Ago Are Still Down 86%, Even After 6.2% Gain This Past Week
Porton Pharma Solutions Ltd.'s (SZSE:300363) Price Is Right But Growth Is LackingNo Data
No Data
